|
|
|
|
|
Teisinis statusas
Patento galiojimo terminas pasibaigęs
| (51) | INT.CL. | C12N 15/115 | (2010.01) |
| C12Q 1/68 | (2018.01) | ||
| A61K 31/7088 | (2006.01) |
| (11) | Patento numeris | 2860251 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14194459.5 |
| Europos patento paraiškos padavimo data | 2005-02-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-04-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-04-11 |
| (46) | Apibrėžties vertimo paskelbimo data | 2018-07-10 |
| (30) | Numeris | Data | Šalis |
| 544542 P | 2004-02-12 | US | |
| 547747 P | 2004-02-25 | US | |
| 581685 P | 2004-06-21 | US | |
| 608048 P | 2004-09-07 | US |
| (72) |
Benedict, Claude, US
Deiner, John, US
Epstein, David, US
Grate, Dilara, US
Keene, Sara Chesworth, US
Kurz, Jeffrey, US
Kurz, Markus, CH
McCauley, Thomas Green, US
Rottman, James, US
Thompson, Kristin, US
Wilson, Charles, US
Zoltoski, Anna J., US
|
| (73) |
Archemix LLC,
601 Montgomery Street, Suite 2020, San Francisco, CA 94111,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Aptamero terapija, naudinga gydant su komplementu susijusias ligas |
| Aptamer therapeutics useful in the treatment of complement-related disorders |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2024-01-31 | 347.00 EUR |